EA201991097A1 - Усовершенствованный способ выявления helicobacter pylori-ассоциированного гастрита и атрофического гастрита с сопутствующими рисками - Google Patents

Усовершенствованный способ выявления helicobacter pylori-ассоциированного гастрита и атрофического гастрита с сопутствующими рисками

Info

Publication number
EA201991097A1
EA201991097A1 EA201991097A EA201991097A EA201991097A1 EA 201991097 A1 EA201991097 A1 EA 201991097A1 EA 201991097 A EA201991097 A EA 201991097A EA 201991097 A EA201991097 A EA 201991097A EA 201991097 A1 EA201991097 A1 EA 201991097A1
Authority
EA
Eurasian Patent Office
Prior art keywords
gastritis
improved method
helicobacter pylori
related risks
detecting helicobacter
Prior art date
Application number
EA201991097A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of EA201991097A1 publication Critical patent/EA201991097A1/ru

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56922—Campylobacter
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16Z—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS, NOT OTHERWISE PROVIDED FOR
    • G16Z99/00—Subject matter not provided for in other main groups of this subclass
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/595—Gastrins; Cholecystokinins [CCK]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G01N2800/062—Gastritis or peptic ulcer disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/26—Infectious diseases, e.g. generalised sepsis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Endocrinology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Согласно иллюстративному аспекту настоящего изобретения предложен усовершенствованный способ скрининга субъектов с симптомами и без симптомов инфекции Helicobacter pylori, атрофического гастрита с сопутствующими рисками и/или нарушенной функции желудка на основе образцов цельной крови, времени отбора образца и температуры хранения образца, а также на основе анализа содержания соответствующего биомаркера.
EA201991097A 2016-11-14 2016-11-14 Усовершенствованный способ выявления helicobacter pylori-ассоциированного гастрита и атрофического гастрита с сопутствующими рисками EA201991097A1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/FI2016/050800 WO2018087419A1 (en) 2016-11-14 2016-11-14 Improved method for detection of helicobacter pylori -gastritis and atrophic gastritis with related risks

Publications (1)

Publication Number Publication Date
EA201991097A1 true EA201991097A1 (ru) 2019-11-29

Family

ID=62109421

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201991097A EA201991097A1 (ru) 2016-11-14 2016-11-14 Усовершенствованный способ выявления helicobacter pylori-ассоциированного гастрита и атрофического гастрита с сопутствующими рисками

Country Status (10)

Country Link
US (1) US20200072852A1 (ru)
EP (1) EP3538896B1 (ru)
JP (1) JP6865280B2 (ru)
KR (1) KR20190085952A (ru)
CN (1) CN110312938A (ru)
EA (1) EA201991097A1 (ru)
ES (1) ES2952945T3 (ru)
FI (1) FI3538896T3 (ru)
PL (1) PL3538896T3 (ru)
WO (1) WO2018087419A1 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102637908B1 (ko) * 2018-12-28 2024-02-20 씨제이제일제당 (주) 헬리코박터 파일로리 연관 질환에 대한 유전자 마커

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003012436A2 (en) * 2001-07-31 2003-02-13 Becton Dickinson And Company Method and system for predicting initial analyte values in stored samples
US20030049698A1 (en) * 2002-10-08 2003-03-13 Wang Timothy C. Diagnosis and treatment of gastrointestinal disease
WO2004088326A2 (en) * 2003-03-28 2004-10-14 Aphton Corporation Gastrin hormone immunoassays
FI116942B (fi) * 2004-05-10 2006-04-13 Biohit Oyj Proteiini- ja peptidistabilointi
FI20065542A0 (fi) * 2006-09-01 2006-09-01 Biohit Oyj Menetelmä ja näytteenottopakkaus vatsan limakalvon tilan arvioimiseksi
RU2519646C2 (ru) * 2007-10-26 2014-06-20 Биохит Оий Способы и продукты для диагностики аутоиммунных заболеваний и рака желудка, связанного с атрофическим гастритом
CN113514647A (zh) * 2014-06-13 2021-10-19 拜奥希特公司 胃泌素-17作为具有增加的数种相关后发病风险的萎缩性胃炎的生物标志物的用途

Also Published As

Publication number Publication date
FI3538896T3 (fi) 2023-08-07
EP3538896A1 (en) 2019-09-18
PL3538896T3 (pl) 2023-11-13
CN110312938A (zh) 2019-10-08
EP3538896A4 (en) 2020-09-02
US20200072852A1 (en) 2020-03-05
JP2019536029A (ja) 2019-12-12
JP6865280B2 (ja) 2021-04-28
WO2018087419A1 (en) 2018-05-17
ES2952945T3 (es) 2023-11-07
KR20190085952A (ko) 2019-07-19
EP3538896B1 (en) 2023-07-19

Similar Documents

Publication Publication Date Title
EA200971124A1 (ru) Множественный анализ образцов крови
EA201991461A1 (ru) Способы и устройства для оценки содержания материалов
BR112018000851A2 (pt) sistemas e métodos para detecção e quantificação aprimoradas de analitos
WO2015070037A3 (en) Polynucleotide conjugates and methods for analyte detection
BR112019006927A2 (pt) dispositivos e métodos para análise de amostra
BR112017025097A2 (pt) método para quantificação espectrométrica de massa de analitos extraídos de um dispositivo de microamostragem
MX2016006455A (es) Dispositivo integrado de fuente-pixel activo para el analisis rapido de especimenes biologicos y quimicos.
EA201792497A1 (ru) Антитела к gitr для диагностики злокачественной опухоли
MX368793B (es) Dispositivo de recogida de fluidos biologicos y sistema de separacion y analisis de fluidos biologicos.
BRPI0807227A2 (pt) métodos e materiais para identificação da origem de um carcinoma de origem primária desconhecida
SE0800724L (sv) Blodviskositetsanalys
BR112014010718A2 (pt) métodos e sistemas para detecção de analito em amostra
MX2016002632A (es) Dispositivo y metodos para usar un dispositivo para la deteccion de hiperamoniemia.
EA201790769A1 (ru) Определение уровней гликозаминогликанов методом масс-спектрометрии
EA201691352A1 (ru) Диагностика рака легкого с помощью циркулирующих опухолевых клеток
AR089233A1 (es) Determinacion de autoanticuerpos en condiciones de baja conductividad y sensibilidad aumentada
MX369610B (es) Metodos, dispositivos y sistemas para analisis de muestras.
WO2016198833A3 (en) Methods for analysing a urine sample
EA201891002A1 (ru) Иммунологический анализ для определения расщепленного высокомолекулярного кининогена
EA201700208A1 (ru) Способ и устройство для обнаружения малярии
WO2019066572A3 (en) Method and device for analyzing target analyte in sample
MY193895A (en) Combination test for colorectal cancer
EA201691497A1 (ru) Способы детектирования и количественного определения имитаторов циркулирующих опухолевых клеток
AR105379A1 (es) Dispositivo para detectar proteínas mal plegadas y sus métodos de uso
EA201991097A1 (ru) Усовершенствованный способ выявления helicobacter pylori-ассоциированного гастрита и атрофического гастрита с сопутствующими рисками